£1
No changevs Feb 2024Active06107635Private limited companyLondon
ALPEX PHARMA (UK) LIMITED
Significant control: Shahbaz Shoja Ardalan
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Alpex Pharma (UK) Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Alpex Pharma (UK) Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ALPEX PHARMA (UK) LIMITED is an active private limited company (company number 06107635) incorporated on 15 February 2007, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 28 February 2025, showing net assets of £1, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 143 comparable companies in London (median £100, upper quartile £10k).
02
Ownership and control
- Mr Shahbaz Shoja Ardalan
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 15 February 200719 yrs ago
- Next accounts due
- 28 November 2026in 34 days
- Confirmation statement due
- 1 March 2027in 127 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs Feb 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £1 | — | — | — | — | — | 0 |
| 29 February 2024 | £1 | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £1 at 28 February 2025
- Incorporated five or more years agoIncorporated 15 February 2007
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 127 days
- Next accounts duein 34 days
- Accounts period endNet assets £1 · micro accounts
- Accounts period endNet assets £1 · micro accounts
- Incorporated
08
Similar companies in London
- INSMED LIMITEDLondon · inc. Jun 2007
- ORIGIN COLOURS LTDLondon · inc. Sept 2007
- SIGA PHARMACEUTICALS (EUROPE) LIMITEDLondon · inc. Jan 2008
- PTGO SEVER UK LIMITEDLondon · inc. May 2008
- HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANYLondon · inc. Sept 2005
- HIKMA UK LIMITEDLondon · inc. Jul 2005
All companies incorporated on 15 February 2007 · in Feb 2007.
09
Reminders for ALPEX PHARMA (UK) LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.